ctrl K

Watchlist Price Alert

Caribou Biosciences Inc. (CRBU)

NASDAQ: CRBU · Real-Time Price · USD

1.25

0.16 (14.68%)

At close: Jun 06, 2025, 3:59 PM

1.28

2.39%

After-hours: Jun 06, 2025, 07:54 PM EDT

Caribou Biosciences Revenue Breakdown

Period Ending	Dec 31, 2024
Reportable Segment Revenue	9.99M
Reportable Segment Revenue Growth	n/a

Revenue by Geography

Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Non-Us Revenue	724K	1.71M	548K	685K
Non-Us Revenue Growth	-57.59%	+211.50%	-20.00%	n/a
United States Revenue	9.27M	32.77M	13.3M	8.91M
United States Revenue Growth	-71.71%	+146.34%	+49.25%	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	9.73M	10.49M	9.84M	10.63M	14.64M	7.75M	9.71M	10.12M	8.91M	8.53M	9.85M	10.04M	9.59M	7.85M	6.76M	5.11M	4.6M	4.17M	3.25M	3.15M	3.49M
Selling, General, and Administrative Revenue Growth	-7.18%	+6.57%	-7.41%	-27.41%	+89.02%	-20.22%	-4.04%	+13.59%	+4.39%	-13.35%	-1.94%	+4.70%	+22.16%	+16.17%	+32.21%	+11.25%	+10.14%	+28.52%	+2.98%	-9.63%	n/a
Research and Development Revenue	35.53M	30.46M	30.42M	35.48M	33.79M	31.28M	28.58M	26.5M	25.71M	25.74M	19.99M	22.58M	13.92M	15.11M	15.83M	12.33M	10.16M	12.02M	6.18M	7.58M	8.64M
Research and Development Revenue Growth	+16.63%	+0.14%	-14.26%	+5.01%	+8.02%	+9.43%	+7.85%	+3.09%	-0.10%	+28.74%	-11.46%	+62.16%	-7.86%	-4.56%	+28.44%	+21.27%	-15.46%	+94.56%	-18.47%	-12.28%	n/a